Furthermore, the ability of GLP-1R agonists to ameliorate neuropathy-related complications, such as cognitive deficits, underscores their broader neuroprotective benefits [43, 44]
Why are neuroscientists interested in GLP-1 receptors instead of only focusing on dopamine
Well, the existing data do not show that." Patients often stop using GLP-1s within a year for a variety of reasons, including cost, meeting their goal weight or gastrointestinal side effects
As you age or continue to push your body, it struggles to produce energy or heal itself like it once did, prolonging the inflammatory phase
If you experience inflammatory conditions such as arthritis, discussing prescription-strength alternativessuch as selective COX-2 inhibitors (under medical supervision)may offer better safety profiles than over-the-counter NSAIDs
References Lopez-Otin, C., Blasco, M